Abstract
Magnitude of Antibody Response and Risk Factors for Reduced Immunogenicity after Two Doses of an Inactivated Whole-Virion COVID-19 Vaccine (CoronaVac<sup>®</sup>)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
